A Machine Learning Using NLP to Predict Long-Term Patient Response
IGI Global eBooks March 13, 2025 K.Suresh Kumar, Sandeep Kumar Davuluri, Lakshman Kumar Kanulla et al. 2 citations
Historical stories and contemporary clinical studies have shown substantial promise for the therapeutic use of psychedelics for the treatment of mood disorders such as depression. Comp360 is COMPASS Pathways' unique synthetic formulation of psilocybin. A recent randomised double-blind phase-II b research showed that it was safe and effective for those with treatment-resistant depression. The...